Reaction

Incision Site Impaired Healing reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 363 reports · 2 co-occurring drugs

As of the last recalculation, Incision Site Impaired Healing appears in 363 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is UPADACITINIB (PRR 22.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Upadacitinib	30	22.9	22.9
Risankizumab-Rzaa	27	20.4	20.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.